|
gptkbp:instanceOf
|
gptkb:company
|
|
gptkbp:annualReport
|
https://www.freseniusmedicalcare.com/en/investors/publications/annual-reports/
|
|
gptkbp:CEO
|
Helen Giza
|
|
gptkbp:competitor
|
gptkb:DaVita_Inc.
gptkb:Baxter_International
gptkb:B._Braun_Melsungen
|
|
gptkbp:countryOfOrigin
|
gptkb:Germany
|
|
gptkbp:focus
|
Chronic kidney failure treatment
Dialysis products
Dialysis services
|
|
gptkbp:founded
|
1996
|
|
gptkbp:foundedBy
|
gptkb:Fresenius_SE_&_Co._KGaA
|
|
gptkbp:hasChair
|
gptkb:Michael_Sen
|
|
gptkbp:headquartersLocation
|
Bad Homburg vor der Höhe, Germany
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Fresenius Medical Care
|
|
gptkbp:industry
|
gptkb:insurance
Medical devices
Dialysis
|
|
gptkbp:ISIN
|
DE0005785802
|
|
gptkbp:legalForm
|
gptkb:company
|
|
gptkbp:listedOn
|
gptkb:DAX
gptkb:MDAX
|
|
gptkbp:logo
|
Fresenius Medical Care logo.svg
|
|
gptkbp:marketCap
|
~€10 billion (2023)
|
|
gptkbp:memberState
|
~150
|
|
gptkbp:netIncome
|
€673 million (2022)
|
|
gptkbp:numberOfDialysisClinics
|
~4,000
|
|
gptkbp:numberOfEmployees
|
~125,000
|
|
gptkbp:numberOfPatientsServed
|
~345,000
|
|
gptkbp:operatesIn
|
Worldwide
|
|
gptkbp:parentCompany
|
gptkb:Fresenius
|
|
gptkbp:products
|
Hemodialysis machines
Dialyzers
Peritoneal dialysis products
Renal pharmaceuticals
|
|
gptkbp:revenue
|
€19.4 billion (2022)
|
|
gptkbp:stockExchange
|
gptkb:New_York_Stock_Exchange
gptkb:Frankfurt_Stock_Exchange
|
|
gptkbp:stockSymbol
|
gptkb:FME
gptkb:FMS
|
|
gptkbp:subsidiary
|
Fresenius Medical Care Asia-Pacific
Fresenius Medical Care North America
|
|
gptkbp:type
|
gptkb:public_company
|
|
gptkbp:website
|
https://www.freseniusmedicalcare.com/
|
|
gptkbp:bfsParent
|
gptkb:Baxter_International_Inc.
gptkb:DaVita_Inc.
gptkb:Fresenius
gptkb:Macquarie_Park_business_district
gptkb:DaVita
|
|
gptkbp:bfsLayer
|
7
|